Labcorp Holdings (LH) Liabilities and Shareholders Equity (2009 - 2026)

Labcorp Holdings has disclosed Liabilities and Shareholders Equity across 18 years of filings, most recently posting $18.5 billion for Q2 2026.

• In Q2 2026, Liabilities and Shareholders Equity rose 2.62% year-over-year to $18.5 billion; the TTM figure through Jun 2026 stood at $74.3 billion (up 2.23% YoY), while the FY2025 annual figure was $18.4 billion, changed 0.07% from the prior year.
• Liabilities and Shareholders Equity came in at $18.5 billion for Q2 2026 at Labcorp Holdings, down from $19.1 billion in the prior quarter.
• In the past five years, Liabilities and Shareholders Equity ranged from a high of $20.7 billion in Q1 2022 to a low of $16.5 billion in Q1 2024.
• Average Liabilities and Shareholders Equity over 5 years is $18.5 billion, with a median of $18.4 billion recorded in 2024.
• The largest YoY upside for Liabilities and Shareholders Equity was 10.22% in 2024 against a maximum downside of 18.16% in 2024.
• Over 5 years, Liabilities and Shareholders Equity stood at $20.2 billion in 2022, then decreased by 17.02% to $16.7 billion in 2023, then grew by 9.89% to $18.4 billion in 2024, then climbed by 0.07% to $18.4 billion in 2025, then gained by 0.76% to $18.5 billion in 2026.
• Per Business Quant data, the three most recent Liabilities and Shareholders Equity figures were $18.5 billion in Q2 2026, $19.1 billion in Q1 2026, and $18.4 billion in Q4 2025.